Literature DB >> 6192376

Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.

S S Hayreh, P Rojas, P Podhajsky, P Montague, R F Woolson.   

Abstract

A prospective natural history study was conducted in 721 eyes with various types of retinal vein occlusion (RVO) to determine the incidence of various types of ocular neovascularization (NV) and the factors that influence the development of ocular NV. The material was 360 eyes with central retinal vein occlusion (CRVO), 97 eyes with hemi-CRVO, and 264 eyes with branch retinal vein occlusion (BRVO); these cases were further subdivided into six groups for logical data analysis: nonischemic CRVO (venous stasis retinopathy-VSR, 282 eyes), ischemic CRVO (hemorrhagic retinopathy-HR, 78 eyes), hemi-VSR (66 eyes), hemi-HR (31 eyes), major BRVO (191 eyes) and macular BRVO (73 eyes). Ocular NV attributable to RVO was seen only in HR, hemi-HR, and major BRVO. In HR the anterior segment was the major site of NV, with iris and angle NV and neovascular glaucoma (NVG), while in hemi-HR and major BRVO the retina and optic disc were the major sites of NV. The principal factor influencing the development of ocular NV in RVO seems to be the severity and extent of retinal ischemia, while duration of follow-up since onset also plays an important role in determining the incidence of ocular NV. The findings and subject of ocular NV in RVO are discussed in detail along with a review of the pertinent literature.

Entities:  

Mesh:

Year:  1983        PMID: 6192376     DOI: 10.1016/s0161-6420(83)34542-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  73 in total

1.  Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.

Authors:  C Hvarfner; A Hillarp; J Larsson
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Relationship between perifoveal capillaries and pathomorphology in macular oedema associated with branch retinal vein occlusion.

Authors:  T Murakami; A Tsujikawa; K Miyamoto; A Sakamoto; M Ota; K Ogino; N Yoshimura
Journal:  Eye (Lond)       Date:  2012-06-01       Impact factor: 3.775

3.  Natural history of visual outcome in central retinal vein occlusion.

Authors:  Sohan Singh Hayreh; Patricia A Podhajsky; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2010-08-17       Impact factor: 12.079

4.  The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary.

Authors:  S Sivaprasad; W M Amoaku; P Hykin
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

5.  Retinal neovascularization in a case of macular branch retinal vein occlusion.

Authors:  G Virgili; S Caucci; P Lanzetta; C Salati; U Menchini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

6.  Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.

Authors:  S S Hayreh; M R Klugman; P Podhajsky; G E Servais; E S Perkins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

7.  Neovascular response in ischaemic central retinal vein occlusion after panretinal photocoagulation.

Authors:  I E Murdoch; P H Rosen; J S Shilling
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

Review 8.  Neovascular glaucoma.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2007-08-08       Impact factor: 21.198

9.  Ocular neovascularization. Experimental animal model and studies on angiogenic factor(s).

Authors:  S S Hayreh; G F Lata
Journal:  Int Ophthalmol       Date:  1986-05       Impact factor: 2.031

Review 10.  Vitreous haemorrhage in elderly patients: management and prevention.

Authors:  Kaykhosrov Manuchehri; Graham Kirkby
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.